GlobalData Plc

Analytical Tools

Sales Analytics

Sales Analytics is GlobalData’s premier Pharmaceutical Industry forecasting Analytical tool where company-reported Sales data are integrated with a seven-year broker derived Analyst Consensus forecasts. This tool is designed to give the user access to critical information to facilitate strategic decision making around Companies and their assets. It allows the user to analyze the overall Pharmaceutical Industry by viewing the entire dataset at once or alternatively performing benchmark analysis using a wide range of search criteria integrated from the Products Database.

Why Choose Our Sales Analytics Tool?

  • Predict launch uptake of new Products to market
  • Assess competitive landscapes
  • Facilitate the due diligence of in/out-licensing and acquisition of Products based on Broker data
  • Company level Sales and forecasts can simulate merger or acquisition opportunities

Who Can Our Sales Analytics Tool Help?

  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations
  • Financial Institutions such as Investment Banks, Venture Capital and Private Equity Firms
  • Professional services firms such as Consultancies, Market Research Firms, and Technology Transfer Offices

NPV Valuation Model

The NPV (Net Present Value) Valuation Model is a fully-interactive Pharmaceutical forecasting and valuation tool. Driven by Analyst Consensus forecasts, this tool enables users to analyze and customize valuations for individual Pharmaceutical assets. The NPV Valuation Model combines a fully-interactive forecasting model with adjustable Operating Cost, Tax, and Discount Rates, in order to derive future cash flows for a chosen Pharmaceutical asset. Additionally the customizable Expiry Model allows users to adjust the forecast based on their estimation of brand erosion and generic competition or alternatively Patent extension.

Why Choose Our NPV Valuation Model?

  • NPV Valuation reveals what the asset is worth today and can be used to influence present-day decision making around that asset
  • Predict launch uptake of new Products to market
  • Assess competitive landscapes
  • Facilitate the due diligence of in/out-licensing and acquisition of Products based on Broker opinion

Who Can Our NPV Valuation Model Help?

  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations
  • Financial Institutions such as Investment Banks, Venture Capital and Private Equity Firms
  • Professional services firms such as Consultancies, Market Research Firms, and Technology Transfer Offices

Financial Analytics

Financial Analytics is a financial benchmarking tool from GlobalData that facilitates financial analysis across public companies operating within the Pharmaceutical and associated Healthcare Sectors on approximately 150 different financial line items and metrics.

Financial Analytics can be used to determine the financial health and performance across a completely customizable set of companies, as well as track historical industry averages across a wide-range of different metrics and line items.

Why Choose Our Financial Analytics Tool?

  • Provides easy benchmarking analysis of corporate financial performance – Top Pharma companies by Revenue, Profit, R&D, SG&A, cash, Capex, etc.
  • Landscape assessments across Company Geography – Top Pharma companies by Revenue located in the US, Europe, Japan, etc.

Who Can Our Financial Analytics Tool Help?

  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations
  • Financial Institutions such as Investment Banks, Venture Capital and Private Equity Firms
  • Professional services firms such as Consultancies, Market Research Firms, and Technology Transfer Offices